Greater transparency from pharmaceutical manufacturers is also required under the legislation.
A bipartisan bill was introduced in the Senate Tuesday that would “expand the availability of low-cost generic drugs.” The legislation, presented by Senator Bernie Sanders of Vermont and Bill Cassidy of Louisiana, the chairman and ranking member respectively of the Senate Committee on Health, Education, Labor, and Pensions, would also increase transparency on how drug prices are established.
The senators stated, “We are happy to announce that we’ve come to an agreement to consider critical pieces of legislation to reform pharmacy benefit managers and expand the availability of low-cost generic drugs through the HELP Committee. We will hold an official markup of the legislation on May 2nd.”
Their bill is one of four that the Senate will mark up next week having to do with access to and pricing of generic drugs.
As the Lord Leads, Pray with Us…
- For members of the Senate as they consider legislation to address access and costs of prescription drugs.
- For wisdom for Senators Sanders and Cassidy as they promote their bill.
Sources: Washington Examiner, Washington Times
